Colon cancer risk and different HRT formulations: a case-control study (Q33284068)

25 July 2017

Colon cancer risk and different HRT formulations: a case-control study (English)

1 reference

Hormone Replacement Therapy

25 July 2017

1 reference

1 reference

Jürgen C Dinger

1

1 reference

25 July 2017

Lothar A J Heinemann

2

1 reference

25 July 2017

Sabine Möhner

3

1 reference

25 July 2017

Do Minh Thai

4

1 reference

25 July 2017

Anita Assmann

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

8 May 2007

1 reference

25 July 2017

1 reference

25 July 2017

7

1 reference

25 July 2017

76

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-7-76

25 July 2017

0 references

cites work

Breast cancer risk associated with different HRT formulations: a register-based case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

Adverse neoplastic and cardiovascular outcomes of HRT: the validity of the evidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

HRT and cancer risk: separating fact from fiction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-7-76

Colorectal cancer and hormone replacement therapy: an unexpected finding

21 January 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1878492

31 October 2018

https://api.crossref.org/works/10.1186%2F1471-2407-7-76

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17488513

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-7-76

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference